Xiaolin Pang

Xiaolin Pang

Auto-generated profile, based on publicly available information

Xiaolin Pang

Department of Radiation Oncology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YWYun-Long Wang
Yun-Long Wang
WZWan-Wen Zhao
Wan-Wen Zhao
SBShao-Mei Bai
Shao-Mei Bai
LFLi-Li Feng
Li-Li Feng
SBShu-Ying Bie
Shu-Ying Bie
XWXiangbo Wan
Xiangbo Wan
The rapid recognition of DNA double-strand breaks (DSBs) by the MRE11/RAD50/NBS1 (MRN) complex is critical for the initiation of DNA damage response and DSB end resection. Here, we show that MRN complex interacting protein (MRNIP) forms liquid-like condensates to promote homologous recombination-mediated DSB repair. The intrinsically disordered region is essential for MRNIP condensate formation. Mechanically, the MRN complex is compartmentalized and concentrated into MRNIP condensates in the nucleus. After DSB formation, MRNIP condensates move to the damaged DNA rapidly to accelerate the binding of DSB by the concentrated MRN complex, therefore inducing the autophosphorylation of ATM and subsequent activation of DNA damage response signaling. Meanwhile, MRNIP condensates-enhanced MRN complex loading further promotes DSB end resection. In addition, data from xenograft models and clinical samples confirm a correlation between MRNIP and radioresistance. Together, these results reveal an important role of MRNIP phase separation in DSB response and the MRN complex-mediated DSB end resection.

6 April 2022 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
XPXiaolin Pang
Xiaolin Pang
PXPeiyi Xie
Peiyi Xie
LYLi Yu
Li Yu
HCHaiyang Chen
Haiyang Chen
JZJian Zheng
Jian Zheng
XWXiangbo Wan
Xiangbo Wan

15 June 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
XPXiaolin Pang
Xiaolin Pang
YGYuanhong Gao
Yuanhong Gao
HYHanchen Yi
Hanchen Yi
HLHailing Liu
Hailing Liu
SLShuai Liu
Shuai Liu
JZJian Zheng
Jian Zheng
Following standard neoadjuvant chemoradiotherapy and total mesorectal excision, some patients with locally advanced rectal cancer achieve good response (pathological T0–2N0), while others show nonresponse (pathological T3–4N0 or node‐positive). To date, the clinicopathological predictors of good response and the necessity of adjuvant chemotherapy treatment (ACT) in good responders remain unclear. In this retrospective study, clinicopathological characteristics were surveyed to investigate the correlation with good response; furthermore, a propensity score matching (PSM) model was designed to balance the confounding factors between good responders treated with ACT or observation. A total of 2255 patients were enrolled, including 1069 good responders and 1186 nonresponders. The results of the survival analysis showed a good response predicted a better 3‐year prognosis (p < 0.001). The logistic regression analysis showed less advanced T and N stages (T3 vs. T4; N0 vs. N1–2), more neoadjuvant chemotherapy (nCT) cycles (≥4 vs. 1–3), and delayed surgery (≥8 weeks vs. <8 weeks) were independent predictors of a good response (p < 0.05). Especially, patients treated with both more nCT cycles and a delay in surgery included the greatest number of good responders (p < 0.001). For good responders, after PSM (1:3), 235 observation cases were matched to 705 ACT cases. As compared with observation, ACT had no greater impact on prognosis analysis (p > 0.05). In conclusion, more cycles of nCT and a delay in surgery predicted a better response, and the delivery of ACT might be omitted in good responders.